CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

RAPS Launches Global Compensation Survey of Regulatory Professionals

APS has launched its biennial survey of healthcare product regulatory professionals around the world, the Global Compensation & Scope of Practice Survey. It is the most comprehensive survey of regulatory professionals’ compensation, education, professional experience, demographics and work responsibilities.
The survey is open to anyone involved in healthcare product regulation or compliance, including those who work in industry, government, law, research, consulting or any other relevant areas. The 2018 survey will close after 18 May.
“RAPS has been conducting this research for more than 20 years, and it has been invaluable in improving understanding of the regulatory profession and its evolution,” said RAPS Executive Director Paul Brooks.
“It also yields extremely useful compensation data, giving individuals, regulatory employers, recruiters and other stakeholders insight into regulatory professionals’ compensation, trends and the factors that most directly influence compensation. This year, we are able to offer participants even greater value by providing them with a personal profile they can use to benchmark themselves against the aggregated survey results.”
The results of the 2018 survey are expected to be released in August. 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026